KA
Kinnevik AB’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68M | Hold |
13,434,171
| – | – | 100% | 1 |
|
|
2025
Q1 | $71.1M | Buy |
13,434,171
+1,528,503
| +13% | +$8.09M | 100% | 1 |
|
|
2024
Q4 | $80.5M | Hold |
11,905,668
| – | – | 100% | 1 |
|
|
2024
Q3 | $78.5M | Hold |
11,905,668
| – | – | 100% | 1 |
|
|
2024
Q2 | $89.3M | Buy |
11,905,668
+1,500,000
| +14% | +$11.3M | 100% | 1 |
|
|
2024
Q1 | $104M | Hold |
10,405,668
| – | – | 100% | 1 |
|
|
2023
Q4 | $103M | Hold |
10,405,668
| – | – | 100% | 1 |
|
|
2023
Q3 | $79.6M | Hold |
10,405,668
| – | – | 100% | 1 |
|
|
2023
Q2 | $77.7M | Buy |
10,405,668
+2,752,607
| +36% | +$20.6M | 100% | 1 |
|
|
2023
Q1 | $51M | Hold |
7,653,061
| – | – | 68.47% | 1 |
|
|
2022
Q4 | $59M | Buy |
+7,653,061
| New | +$59M | 33.28% | 2 |
|